IMO, when revenue comes in from Striate + being FDA approved Institutional investors will come in. Don't Forget in Australia Biotech companies are not understood well by Fund manager but when they see a revenue stream, things will change, and quickly.
IMO, when revenue comes in from Striate + being FDA approved...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
64.0¢ |
Change
0.090(16.4%) |
Mkt cap ! $134.1M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 67.0¢ | 56.5¢ | $1.465M | 2.358M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 725 | 64.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.5¢ | 14150 | 2 |
View Market Depth
| Last trade - 13.52pm 10/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |